journal article·2017-03-01

Mesoporous Silica Nanoparticles as an Antitumoral-Angiogenesis Strategy

Magdiel I. Setyawati, David T. Leong

Publisher page

Abstract

Tumors depend heavily on angiogenesis for nutrient derivation and their subsequent metastasis. Targeting tumor induced angiogenesis per se can address both tumor growth and progression simultaneously. Here, we show that we could elegantly restrict the endothelial cells angiogenic behavior through digital size control of mesoporous silica nanoparticle (MSN). This antiangiogenesis effect was derived from the particle size dependent uptake and production of intracellular reactive oxygen species (ROS) that directly interfered with p53 tumor suppressor pathway. The resulting signaling cascade wrestled back the tumoral control of endothelial cells' migration, invasion, and proliferation. Overall, a mere control over the size of a highly oxidative reactive surfaced nanoparticle could provide an alternative strategy to curb the tumor induced angiogenesis process in a conventional drug-free manner.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Angiogenesis and VEGF in Cancer · Nanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemical and Biomolecular Engineering, National University of Singapore, 4 Engineering Drive 4, Singapore 117585, Singapore

Funding

Ministry of Education - Singapore

References (75)

Show source-provided references
1. Cancer;World Health Organization, 2016.http://www.who.int/cancer/en/(accessed May 15, 2016).
2. 10.1038/nrc188610.1038/nrc1886 ↗
3. 10.1038/nrc109310.1038/nrc1093 ↗
4. 10.1038/3502522010.1038/35025220 ↗
5. 10.1038/sj.bjc.660448310.1038/sj.bjc.6604483 ↗
6. 10.2217/17435889.1.1.1710.2217/17435889.1.1.17 ↗
7. 10.1039/C5NR07887C10.1039/C5NR07887C ↗
8. 10.1038/nature0448310.1038/nature04483 ↗
9. 10.1002/adma.20140155010.1002/adma.201401550 ↗
10. 10.1021/acsami.5b0075210.1021/acsami.5b00752 ↗
11. 10.1021/am302512u10.1021/am302512u ↗
12. 10.1021/acsami.6b0688310.1021/acsami.6b06883 ↗
13. 10.1016/j.nano.2014.09.01410.1016/j.nano.2014.09.014 ↗
14. 10.1002/adma.20130312310.1002/adma.201303123 ↗
15. 10.2217/17435889.3.5.70310.2217/17435889.3.5.703 ↗
16. 10.1039/C5CS00499C10.1039/C5CS00499C ↗
17. 10.1021/acsnano.5b0648710.1021/acsnano.5b06487 ↗
18. 10.1016/j.jcis.2012.03.01410.1016/j.jcis.2012.03.014 ↗
19. 10.1016/j.biomaterials.2015.01.07210.1016/j.biomaterials.2015.01.072 ↗
20. 10.1038/ncomms319710.1038/ncomms3197 ↗
21. 10.1289/ehp.908733710.1289/ehp.9087337 ↗
22. 10.1002/adfm.20140166410.1002/adfm.201401664 ↗
23. 10.1021/am501266a10.1021/am501266a ↗
24. 10.1038/ncomms265510.1038/ncomms2655 ↗
25. 10.1038/nprot.2010.610.1038/nprot.2010.6 ↗
26. 10.1200/JCO.2005.06.08110.1200/JCO.2005.06.081 ↗
27. 10.1158/0008-5472.CAN-07-078310.1158/0008-5472.CAN-07-0783 ↗
28. 10.1023/B:MCBI.0000044378.09409.b510.1023/B:MCBI.0000044378.09409.b5 ↗
29. 10.1038/3504168710.1038/35041687 ↗
30. 10.1155/2013/94291610.1155/2013/942916 ↗
31. 10.1021/sc500152g10.1021/sc500152g ↗
32. 10.1021/nl403949h10.1021/nl403949h ↗
33. 10.1016/j.tips.2005.02.00510.1016/j.tips.2005.02.005 ↗
34. 10.1089/ten.tec.2012.068410.1089/ten.tec.2012.0684 ↗
35. 10.1038/nrclinonc.2012.12010.1038/nrclinonc.2012.120 ↗
36. 10.1038/nrm154910.1038/nrm1549 ↗
37. 10.1038/3509906610.1038/35099066 ↗
38. 10.1038/377539a010.1038/377539a0 ↗
39. 10.1242/jcs.04790210.1242/jcs.047902 ↗
40. 10.1091/mbc.E05-02-017010.1091/mbc.E05-02-0170 ↗
41. 10.1083/jcb.20070303610.1083/jcb.200703036 ↗
42. 10.1016/j.cub.2013.01.00910.1016/j.cub.2013.01.009 ↗
43. 10.1038/bjc.2013.67510.1038/bjc.2013.675 ↗
44. 10.1242/jcs.11272210.1242/jcs.112722 ↗
45. 10.1128/MCB.15.5.263510.1128/MCB.15.5.2635 ↗
46. 10.1016/S1357-2725(01)00171-610.1016/S1357-2725(01)00171-6 ↗
47. 10.1242/jcs.0343110.1242/jcs.03431 ↗
48. 10.1074/jbc.M113.47250610.1074/jbc.M113.472506 ↗
49. 10.1073/pnas.85.16.594610.1073/pnas.85.16.5946 ↗
50. 10.1016/S1674-8301(11)60032-810.1016/S1674-8301(11)60032-8 ↗
51. 10.1371/journal.pone.001594010.1371/journal.pone.0015940 ↗
52. 10.1159/00035867410.1159/000358674 ↗
53. 10.1038/sj.onc.120454110.1038/sj.onc.1204541 ↗
54. 10.1038/sj.onc.120861510.1038/sj.onc.1208615 ↗
55. 10.1038/sj.onc.121042110.1038/sj.onc.1210421 ↗
56. 10.4161/cbt.3.2.61410.4161/cbt.3.2.614 ↗
57. 10.1083/jcb.20100905910.1083/jcb.201009059 ↗
58. 10.1042/BC2005005810.1042/BC20050058 ↗
59. 10.1038/nm132010.1038/nm1320 ↗
60. 10.1038/nrm239510.1038/nrm2395 ↗
61. 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-910.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9 ↗
62. 10.1073/pnas.97.12.642710.1073/pnas.97.12.6427 ↗
63. 10.1038/bjc.2011.34810.1038/bjc.2011.348 ↗
64. 10.3390/ijms1504601910.3390/ijms15046019 ↗
65. 10.1073/pnas.030867110010.1073/pnas.0308671100 ↗
66. 10.2174/13894500878590934710.2174/138945008785909347 ↗
67. 10.1182/blood-2011-01-33169410.1182/blood-2011-01-331694 ↗
68. 10.1016/j.addr.2014.06.00710.1016/j.addr.2014.06.007 ↗
69. 10.1002/smll.20140191510.1002/smll.201401915 ↗
70. 10.1002/adfm.20160047610.1002/adfm.201600476 ↗
71. 10.1002/smll.20150230610.1002/smll.201502306 ↗
72. 10.1002/adma.20120447210.1002/adma.201204472 ↗
73. 10.1016/j.nano.2011.01.01110.1016/j.nano.2011.01.011 ↗
74. 10.1101/cshperspect.a00653610.1101/cshperspect.a006536 ↗
75. 10.1371/journal.pone.012331210.1371/journal.pone.0123312 ↗